Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia
This study has been completed.
Study NCT00244192   Information provided by Center for Integrated Rehabilitation and Organ Failure Horn
First Received: October 25, 2005   Last Updated: December 8, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
COPD
Cachexia
Additional conditions recognized in this trial
Pulmonary Disease, Chronic Obstructive
Stress, Psychological
More general conditions related to this trial
Behavioral Symptoms
Body Weight
Body Weight Changes
Emaciation
Lung Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases
Signs and Symptoms
Weight Loss
Interventions listed in this trial
infliximab (Remicade)
Additional drug interventions recognized in this trial
Infliximab
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antirheumatic Agents
Dermatologic Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Center for Integrated Rehabilitation and Organ Failure Horn
Centocor, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services